跳到主要內容

Werewolf Therapeutics, Inc.

HOWL
交易所
Nasdaq
產業
Pharmaceutical Preparations
SEC CIK
0001785530

近 90 天,Werewolf Therapeutics, Inc. 沒有內部人公開市場買賣的申報;2026 年第 3 季末有 46 家機構在 13F 申報持有,市值合計 $1,185 萬;沒有大師持有。

持有 HOWL 5% 以上的大股東

最新一份 Schedule 13D 或 13G 申報持有 Werewolf Therapeutics, Inc. 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。

持有 HOWL 5% 以上的大股東
持有人最新表單持股變化首次申報最新申報原文
Balyasny Asset Management LLC13G6.26%股數 304.0 萬新申報2026/11/161 份2026/11/16SEC
Moll Peter13G5.20%股數 253.7 萬新申報2026/9/211 份2026/9/21SEC

持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。

13D 與 13G 申報

Werewolf Therapeutics, Inc. 的 43 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。

HOWL 的 Schedule 13D、13G 申報
申報時間(美東)申報人表單持股變化事件日原文
2026/11/1606:03 ETBalyasny Asset Management LLC等 5 位13G6.26%股數 304.0 萬新申報2026/9/30SEC
2026/9/2111:11 ETMoll Peter13G5.20%股數 253.7 萬新申報2026/9/18SEC
2026/7/220:26 ETRa Capital Management, L.P.等 4 位13D/A4.10%股數 198.6 萬−1.90 個百分點原本 6.00%低於 5%2026/6/30SEC
2026/6/2617:39 ETRa Capital Management, L.P.等 4 位13D/A6.00%股數 291.6 萬−1.50 個百分點原本 7.50%2026/6/24SEC
2026/6/2219:02 ETRa Capital Management, L.P.等 4 位13D/A7.50%股數 365.4 萬−3.10 個百分點原本 10.60%2026/6/17SEC
2026/6/1520:16 ETRa Capital Management, L.P.等 4 位13D/A10.60%股數 513.9 萬−2.00 個百分點原本 12.60%2026/6/11SEC
2026/5/1417:23 ETRa Capital Management, L.P.等 4 位13D/A12.60%股數 611.6 萬−1.20 個百分點原本 13.80%2026/5/12SEC
2026/5/1219:56 ETMPM BioVentures 2014, L.P.等 14 位13D/A3.80%股數 182.7 萬−1.60 個百分點原本 5.40%低於 5%2026/5/8SEC
2026/5/519:04 ETMPM BioVentures 2014, L.P.等 14 位13D/A5.40%股數 260.9 萬−1.50 個百分點原本 6.90%2026/5/1SEC
2026/2/1115:46 ETLongwood Fund III, L.P.等 2 位13G/A3.50%股數 167.7 萬–低於 5%2025/12/31SEC
2026/1/1617:36 ETMPM BioVentures 2014, L.P.等 14 位13D/A6.90%股數 336.9 萬−1.30 個百分點原本 8.20%2026/1/14SEC
2025/12/2918:59 ETMPM BioVentures 2014, L.P.等 14 位13D/A8.20%股數 397.8 萬−1.80 個百分點原本 10.00%2025/12/22SEC
2025/12/319:04 ETMPM BioVentures 2014, L.P.等 14 位13D/A10.00%股數 486.7 萬−1.30 個百分點原本 11.30%2025/12/1SEC
2025/11/1720:00 ETMPM BioVentures 2014, L.P.等 14 位13D/A11.30%股數 548.2 萬−2.10 個百分點原本 13.40%2025/11/13SEC
2025/11/616:29 ETRa Capital Management, L.P.等 4 位13D/A13.80%股數 668.1 萬−1.20 個百分點原本 15.00%2025/11/4SEC
2025/11/418:33 ETMPM BioVentures 2014, L.P.等 14 位13D/A13.40%股數 614.8 萬–2025/10/31SEC
2025/8/1416:48 ETPFM Health Sciences, LP等 4 位13G/A0.90%股數 40.1 萬−5.60 個百分點原本 6.50%低於 5%2025/6/30SEC
2025/5/1418:09 ETRa Capital Management, L.P.等 4 位13D/A15.00%股數 674.7 萬–2025/5/12SEC
2025/2/1416:07 ETPFM Health Sciences, LP等 4 位13G/A6.50%股數 290.5 萬–2024/12/31SEC
2024/11/14PFM Health Sciences, LP13G/A舊制–––SEC
2024/11/14Bank of America Corp13G/A舊制–––SEC
2024/11/13Rubric Capital Management LP13G/A舊制–––SEC
2024/11/12Adage Capital Management, L.P.13G/A舊制–––SEC
2024/5/7Ra Capital Management, L.P.13D/A舊制–––SEC
2024/2/14Ra Capital Management, L.P.13D/A舊制–––SEC
2024/2/14PFM Health Sciences, LP13G/A舊制–––SEC
2024/2/13Bank of America Corp13G舊制–新申報–SEC
2024/2/12Rubric Capital Management LP13G/A舊制–––SEC
2023/12/21Adage Capital Partners GP, L.L.C.13G舊制–新申報–SEC
2023/2/10Rubric Capital Management LP13G舊制–新申報–SEC
2023/1/17PFM Health Sciences, LP13G舊制–––SEC
2023/1/17PFM Health Sciences, LP13G/A舊制–––SEC
2023/1/10Ra Capital Management, L.P.13D/A舊制–––SEC
2022/8/12Ra Capital Management, L.P.13D/A舊制–––SEC
2022/5/2PFM Health Sciences, LP13G舊制–新申報–SEC
2022/2/11Flynn James E13G/A舊制–––SEC
2021/6/16Ra Capital Management, L.P.13D/A舊制–––SEC
2021/5/14MPM BioVentures 2014, L.P.13D舊制–新申報–SEC
2021/5/14Longwood Fund III GP, LLC13G舊制–新申報–SEC
2021/5/13Taiho Ventures LLC13D舊制–新申報–SEC
2021/5/10Arkin Moshe13D舊制–新申報–SEC
2021/5/6Ra Capital Management, L.P.13D舊制–新申報–SEC
2021/5/4Flynn James E13G舊制–新申報–SEC

Form 144:內部人預計賣出

高階主管、董事與其他關係人預計賣出 Werewolf Therapeutics, Inc. 股票的 114 份通知,由新到舊。

HOWL 的 Form 144
申報時間(美東)賣方預計賣出股數市值預計賣出日券商原文
2026/7/617:19 ETMPM Oncology Innovations Fund, L.P.股東2.12 萬$7,214.442026/7/610b5-1Merrill LynchSEC
2026/7/617:19 ETMPM Asset Management Investors BV2014 LLC股東3,332$1,134.212026/7/610b5-1Merrill LynchSEC
2026/7/617:19 ETMPM Asset Management LLC股東1.53 萬$5,222.082026/7/610b5-1Merrill LynchSEC
2026/7/617:18 ETUBS Oncology Impact Fund, L.P.股東8.01 萬$2.73 萬2026/7/610b5-1Merrill LynchSEC
2026/7/617:18 ETMPM BioVentures 2014 (B), L.P.股東6,459$2,198.642026/7/610b5-1Merrill LynchSEC
2026/7/617:18 ETMPM BioVentures 2014, L.P.股東9.69 萬$3.30 萬2026/7/610b5-1Merrill LynchSEC
2026/6/2917:30 ETMPM Oncology Innovations Fund, L.P.股東2.32 萬$7,509.12026/6/2910b5-1Merrill LynchSEC
2026/6/2917:30 ETMPM Asset Management Investors BV2014 LLC股東3,657$1,181.212026/6/2910b5-1Merrill LynchSEC
2026/6/2917:29 ETMPM Asset Management LLC股東1.68 萬$5,436.092026/6/2910b5-1Merrill LynchSEC
2026/6/2917:29 ETUBS Oncology Impact Fund, L.P.股東8.79 萬$2.84 萬2026/6/2910b5-1Merrill LynchSEC
2026/6/2917:29 ETMPM BioVentures 2014 (B), L.P.股東7,087$2,289.12026/6/2910b5-1Merrill LynchSEC
2026/6/2917:29 ETMPM BioVentures 2014, L.P.股東10.6 萬$3.43 萬2026/6/2910b5-1Merrill LynchSEC
2026/5/2817:04 ETMPM BioVentures 2014, L.P.股東24.4 萬$12.0 萬2026/5/2810b5-1Merrill LynchSEC
2026/5/2817:03 ETMPM BioVentures 2014 (B), L.P.股東1.63 萬$7,980.632026/5/2810b5-1Merrill LynchSEC
2026/5/2817:03 ETUBS Oncology Impact Fund, L.P.股東20.2 萬$9.90 萬2026/5/2810b5-1Merrill LynchSEC
2026/5/2817:03 ETMPM Asset Management LLC股東3.87 萬$1.90 萬2026/5/2810b5-1Merrill LynchSEC
2026/5/2817:03 ETMPM Asset Management Investors BV2014 LLC股東8,405$4,118.452026/5/2810b5-1Merrill LynchSEC
2026/5/2817:02 ETMPM Oncology Innovations Fund, L.P.股東5.34 萬$2.62 萬2026/5/2810b5-1Merrill LynchSEC
2026/5/1817:03 ETMPM Oncology Innovations Fund, L.P.股東6.35 萬$3.27 萬2026/5/1810b5-1Merrill LynchSEC
2026/5/1817:02 ETMPM BioVentures 2014, L.P.股東29.0 萬$15.0 萬2026/5/1810b5-1Merrill LynchSEC
2026/5/1817:02 ETMPM BioVentures 2014 (B), L.P.股東1.94 萬$9,977.492026/5/1810b5-1Merrill LynchSEC
2026/5/1817:02 ETUBS Oncology Impact Fund, L.P.股東24.0 萬$12.4 萬2026/5/1810b5-1Merrill LynchSEC
2026/5/1817:01 ETMPM Asset Management LLC股東4.60 萬$2.37 萬2026/5/1810b5-1Merrill LynchSEC
2026/5/1817:01 ETMPM Asset Management Investors BV2014 LLC股東9,996$5,148.942026/5/1810b5-1Merrill LynchSEC
2026/5/1116:33 ETMPM Oncology Innovations Fund, L.P.股東1.85 萬$1.26 萬2026/5/1110b5-1Merrill LynchSEC

只列最新的 25 份。看 HOWL 近 12 個月的全部通知